NEPH Nephros Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: NEPH

Price (delayed)

$4.625

Market cap

$50.23M

P/E Ratio

30.83

Dividend/share

N/A

EPS

$0.15

Enterprise value

$46.4M

?
Relative Growth: Rel. Growth: 81
Relative Strength: Rel. Strength: 68
Relative Valuation: Rel. Valuation: 48
Relative Profitability: Rel. Profitability: 79

Nephros is committed to improving the human relationship with water through leading, accessible technology. We provide innovative water filtration products and services, along with water-quality education, as part of an ...

Highlights
The EPS has soared by 150% from the previous quarter and by 15% YoY
Nephros's net income has soared by 124% from the previous quarter and by 31% YoY
The company's gross margin fell by 3.3% YoY but it rose by 2.3% QoQ
The company's quick ratio fell by 34% YoY and by 12% QoQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.nephros.com
Peers: RMTI BSX TMO DHR

Key stats

What are the main financial stats of NEPH

NEPH stock price

How has the Nephros stock price performed over time
Intraday
-1.39%
1 week
9.86%
1 month
30.28%
1 year
15.63%
YTD
-5.23%
QTD
29.55%

Financial performance

How have Nephros's revenue and profit performed over time
Revenue
$20.72M
Gross profit
$12.7M
Operating income
$1.64M
Net income
$1.74M
Gross margin
61.3%
Net margin
8.4%
The company's operating income has surged by 143% QoQ and by 23% YoY
The operating margin has soared by 126% QoQ
Nephros's net income has soared by 124% from the previous quarter and by 31% YoY
The company's net margin has surged by 105% QoQ and by 5% YoY

Price vs fundamentals

How does NEPH's price correlate with its fundamentals

Growth

What is Nephros's growth rate over time

Valuation

What is Nephros stock price valuation
P/E
30.83
P/B
4.2
P/S
2.42
EV/EBIT
26.47
EV/EBITDA
24.76
EV/Sales
2.24
The EPS has soared by 150% from the previous quarter and by 15% YoY
NEPH's P/E is 19% below its last 4 quarters average of 37.9
NEPH's price to book (P/B) is 31% more than its 5-year quarterly average of 3.2 and 2.4% more than its last 4 quarters average of 4.1
Nephros's equity has increased by 25% YoY and by 12% QoQ
The revenue has grown by 24% YoY and by 8% from the previous quarter
The price to sales (P/S) is 5% higher than the last 4 quarters average of 2.3

Efficiency

How efficient is Nephros business performance
The ROE has soared by 110% from the previous quarter and by 9% YoY
The return on assets has surged by 108% since the previous quarter and by 6% year-on-year
The ROS has soared by 107% from the previous quarter and by 4.9% YoY
Nephros's ROIC has soared by 104% from the previous quarter and by 26% YoY

Dividends

What is NEPH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NEPH.

Financial health

How did Nephros financials performed over time
The total liabilities rose by 44% YoY and by 23% QoQ
The company's quick ratio fell by 34% YoY and by 12% QoQ
The company's debt is 93% lower than its equity
The debt to equity has declined by 46% year-on-year and by 22% since the previous quarter
The company's debt fell by 30% YoY and by 10% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.